Javier Castillo‐Olivares

A Modified Vaccinia Ankara Virus (MVA) Vaccine Expressing African Horse Sickness Virus (AHSV) VP2 Protects Against AHSV Challenge in an IFNAR −/− Mouse Model

Javier Castillo‐Olivares, Eva Calvo-Pinilla, Isabel Casanova et al. · PLoS ONE · 2011 · 65 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Vaccination of horses with a recombinant modified vaccinia Ankara virus (MVA) expressing African horse sickness (AHS) virus major capsid protein VP2 provides complete clinical protection against challenge

Berta Alberca, Katarzyna Bachanek‐Bankowska, Marta Cabana et al. · Vaccine · 2014 · 52 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Protection of IFNAR (−/−) Mice against Bluetongue Virus Serotype 8, by Heterologous (DNA/rMVA) and Homologous (rMVA/rMVA) Vaccination, Expressing Outer-Capsid Protein VP2

Tamara Jabbar, Eva Calvo-Pinilla, Francisco Mateos et al. · PLoS ONE · 2013 · 51 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Antibody correlates of protection from SARS-CoV-2 reinfection prior to vaccination: A nested case-control within the SIREN study

Ana Atti, Ferdinando Insalata, Edward J Carr et al. · Journal of Infection · 2022 · 49 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Induction of Antibody Responses to African Horse Sickness Virus (AHSV) in Ponies after Vaccination with Recombinant Modified Vaccinia Ankara (MVA)

Rachael Chiam, Emma L. Sharp, Sushila Maan et al. · PLoS ONE · 2009 · 46 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17